Sweat Gland Carcinoma

subtype

Identifier: CI-CAN-00004046
Entity page: /cancer/sweat-gland-carcinoma ↗
Edges: 11

Neighbours: 3 drugs8 trials
Drawn: 11 of 11 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Sweat Gland Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived3 of 3
→ investigated in trials for	Nivolumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants	—	—	Sweat Gland Carcinoma	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Bleomycin 1 trials (1 active) · roll-up of the cancer and its descendants	—	—

Sweat Gland Carcinoma studied in …STUDIED_INderived8 of 8
→ studied in	NCT02978625Phase 2 · active not recruiting Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Sweat Gland Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03713203NA · recruiting PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV). · condition mapped ALIAS · 8 trials mapped (5 active)	—	—	Vulvar Paget Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Apocrine Carcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06715592Phase 2 · active not recruiting ECT STUDY High-grade or Initially Invasive Vulva - GinOnc-ECT Study · condition mapped ALIAS · 8 trials mapped (5 active)	—	—	Vulvar Paget Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT05797415recruiting Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Porocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03647631completed Sentinel Lymph Node Biopsy in Porocarcinoma · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)	—	—	Porocarcinoma	1	Observed	clinicaltrials	graph →
→ studied in	NCT02223975suspended Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease · condition mapped ALIAS · 8 trials mapped (5 active)	—	—	Vulvar Paget Disease	1	Observed	clinicaltrials	graph →
→ studied in	NCT00897442completed Collecting Tumor Samples From Patients With Gynecological Tumors · condition mapped ALIAS · 8 trials mapped (5 active)	—	—	Vulvar Paget Disease	1	Observed	clinicaltrials	graph →

Sweat Gland Carcinoma studied in …STUDIED_INderived8 of 8

→ studied in

NCT02978625Phase 2 · active not recruiting

Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)

—

Sweat Gland Carcinoma

Observed

clinicaltrials

graph →

→ studied in

NCT03713203NA · recruiting

PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV). · condition mapped ALIAS · 8 trials mapped (5 active)

—

Vulvar Paget Disease

Observed

clinicaltrials

graph →

→ studied in

NCT06638931Phase 2 · recruiting

Agnostic Therapy in Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 8 trials mapped (5 active)

—

Apocrine Carcinoma

Observed

clinicaltrials